Topline Phase 3 TRIUMPH-1 trial results show retatrutide drives a 30.3 percent body weight loss over 104 weeks of treatment.

Earlier this week, Definium Therapeutics reported that its Phase 3 Emerge trial of DT120 ODT in major depressive disorder met its primary and all key secondary endpoints, showing rapid and durable ...

Pfizer Inc. PFE shares are trading flat during Wednesday’s premarket session as traders weigh mixed Phase 3 trial headlines ...

Aftermath Silver Ltd (TSX-V:AAG, OTCQX:AAGFF, FRA:FLM1) has released additional assay results from its Phase 3 diamond drill program at the Berenguela silver-copper-manganese deposit in southern Peru.

C-FORWARD and C-BEYOND Represent the First Global Phase 3 Head-to-Head Trials of Direct-Acting Antivirals for the Treatment of HCV BOSTON, June 25, 2026 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc.

Definium Therapeutics Inc. DFTX shares are surging Monday after the company announced positive topline results from its Phase ...

Galectin Therapeutics is a Buy as recent FDA alignment de-risks belapectin’s Phase 3 path and clarifies regulatory endpoints.

Atrasentan vs placebo reduces proteinuria and supports slowing of kidney function decline when combined with standard therapies over 2.5 years in adults ...

Definium Therapeutics shares surged in premarket trading Monday after the company reported strong phase 3 results for its experimental depression treatment. Shares traded 50% higher ahead of the ...